Vanguard Global Advisers’s Dare Bioscience DARE Stock Holding History

Vanguard Global Advisers’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.2K	Hold	2,940	–	–	﹤0.01%	3534
2026 Q1	$5.35K	Buy	+2,940	New	+$5.03K	﹤0.01%	3551

Other funds holding DARE

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Global Advisers's DARE Position: Q2 2026 in Review

Vanguard Global Advisers held its Dare Bioscience (DARE) position steady in Q2 2026 at 2,940 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

Vanguard Global Advisers first reported a position in DARE in Q1 2026 and has held it in 2 quarters since. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

Vanguard Global Advisers held 2,940 shares of Dare Bioscience worth $6.2K as of Q2 2026.
Vanguard Global Advisers left its Dare Bioscience share count unchanged in Q2 2026.
Dare Bioscience made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3534 holding.
Vanguard Global Advisers first reported a position in Dare Bioscience in Q1 2026 and has held it in 2 quarters since.
27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.